Both vitiligo and psoriasis are driven by proinflammatory cytokines, with IFN-γ and TNF-α playing central roles in vitiligo, while IL-17, IL-23, and TNF-α are key in psoriasis, exacerbating damage through ROS in both conditions. This evidence concerns the gene IL17A and psoriasis.